Abstract Search

ba0007p157 | (1) | ICCBH2019

Gonadotrophin releasing hormone analogues utilised in late and post-pubertal adolescents causes a reduction in bone density in transgender teenagers attending a national gender dysphoria clinic

Tseretopoulou Xanthippi , Amin Nadia , Sabah Alvi , Mushtaq Talat

Objectives: Gender Dysphoria (GD) occurs when a persons gender identity differs from their biological sex. GID presenting in childhood can dissipate at puberty. If it persists, physical interventions commence with the use of a GnRH analogues (GnRHa) for one year followed by cross sex hormones.Methods: Adolescents with a diagnosis of GD were reviewed in a national GD clinic at Leeds Teaching Hospitals, UK. Standardised medical assessments included c...

0 shares

Bone Abstracts

Gonadotrophin releasing hormone analogues utilised in late and post-pubertal adolescents causes a reduction in bone density in transgender teenagers attending a national gender dysphoria clinic

BiosciAbstracts